Daybreak

What Daybreak does

Daybreak (legal entity: Sleepcare LLC d/b/a Daybreak) is a US-based, privately held telehealth and medical-device company founded in 2022 that delivers end-to-end at-home diagnosis and treatment for obstructive sleep apnea. Its core offering combines a two-night wireless finger-worn at-home sleep test (paired with a mobile app that transmits data to physicians) with a custom-fit, FDA-cleared mandibular advancement device (MAD) fabricated from patient-taken dental impressions, supported by a virtual dentist-led care model and physician-reviewed diagnosis.

The technology stack is intentionally lean: a wearable diagnostic sensor, a mobile companion app for data transmission, a custom oral appliance manufactured from mailed impression kits, and an accessories line (Morning Repositioner, Ultrasonic Cleaner) that wraps the workflow. Daybreak's clinical care is delivered through affiliated medical professional entities (Beluga Health PC) across non-overlapping US jurisdictions, with physician sign-off on diagnosis and ongoing dental oversight of device titration. The company claims 98% accuracy in detecting sleep apnea via the home test and a 90% treatment success rate for the Daybreak Device.

Commercially, Daybreak operates a direct-to-consumer e-commerce model on thedaybreak.com, accepting most health insurance plans as well as FSA/HSA accounts and offering Synchrony-backed installment financing. Revenue streams mix one-time sales (sleep test, impression kit) with multi-year device subscriptions that bundle the custom MAD, clinical follow-up, and replacement components under a 3-year warranty and a results-backed patient care guarantee. Distribution is being extended through a 2026 partnership with Veterans Healthcare Supply Solutions into VA, DoD, and Indian Healthcare Services channels, and the company is participating as the MAD-therapy arm in a $14M PCORI-funded University of Arizona clinical trial across four academic medical centers. Customer segments are primarily adults with OSA symptoms seeking a CPAP alternative, with secondary focus on veterans and snoring-only self-pay patients.

Name

Daybreak

Legal name

Sleepcare LLC d/b/a Daybreak

Website

https://thedaybreak.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Daybreak is a US telehealth and medical-device company that provides at-home diagnosis and treatment of obstructive sleep apnea via a wireless home sleep test and an FDA-cleared custom mandibular advancement device, serving self-pay and insured adult patients as a CPAP alternative.

Ownership category

akta.pro rank

Product category

Sleep Apnea Treatment Medical Devices

NAICS

Offices of Dentists (6212), Offices of Physicians (6211)

SIC

Services-Health Services (8000)

akta.pro primary industry

Sleep & Airway Orthodontics (OSA Appliances/Expansion) (HLABABAI)

akta.pro secondary industries

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF), Sleep Medicine Clinic (HLAKANAB)

Keywords

• Sleep apnea treatment
• At-home sleep testing
• Oral appliance therapy
• Mandibular advancement devices
• Telehealth sleep care

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device Sales: Sales of at-home sleep test kits and custom mandibular advancement devices (MAD) to patients. Sleep test purchased upfront; device pricing not publicly disclosed.
2. Insurance Reimbursement: Daybreak accepts health insurance coverage for the Daybreak Device. Company handles insurance verification and claims submission on behalf of patients.
3. Subscription Services: Ongoing services including clinical follow-up, device adjustments, and replacement components. Auto-renewal subscriptions for device refills and ongoing care.
4. Financing Services: Partnership with Synchrony for sleep testing financing, enabling installment payment options for patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Daybreak provides an end-to-end, at-home obstructive sleep apnea (OSA) diagnosis and treatment platform. Patients order a wireless two-night At-Home Sleep Test, receive a virtual physician diagnosis, and are fitted with an FDA-cleared custom mandibular advancement device (MAD) — a discreet, pocket-sized CPAP alternative — backed by virtual dentist-led care, insurance processing, and a 3-year warranty with a results-backed Patient Care Guarantee.

Product overview

Daybreak offers a telehealth-based, at-home diagnosis and treatment platform for obstructive sleep apnea (OSA). The core offering consists of the Daybreak Device (FDA-cleared custom mandibular advancement device) and the At-Home Sleep Test, supported by At-Home Impression Kits and the Morning Repositioner accessory. The company delivers everything virtually from diagnosis through treatment, including virtual doctor visits and insurance billing management. The Daybreak Sleep System bundles the core device with the impression kit for first-time purchasers, while additional accessories like the Ultrasonic Cleaner and Essentials Bundle are available separately.

Differentiator

Problem solved

Functional benefit

Products and services

• Daybreak Device
• At-Home Sleep Test A two-night wireless at-home sleep test that wraps around the finger and pairs with a mobile app to transmit data to Daybreak's physicians for review and OSA diagnosis. Marketed at 98% accuracy and FSA/HSA eligible; for adults who suspect they may have sleep apnea.
• Daybreak Sleep System Bundled offering that includes the At-Home Sleep Test, At-Home Impression Kit, and custom Daybreak Device for first-time patients. Return requests must be made within 30 days of purchase, and clinical disqualification results in an automatic full refund.
• Morning Repositioner Standalone accessory device worn every morning for at least 5–10 minutes to restore natural bite and minimize side effects from wearing the Daybreak Device.
• At-Home Impression Kit Dental impression kit shipped to patients so they can take their own dental impressions at home; used to manufacture the custom-fit Daybreak Device. Must be unused, unopened, and in original packaging to be eligible for return.
• Ultrasonic Cleaner Non-custom accessory used to clean the Daybreak Device; eligible for return within 14 days if unused, unopened, and in original packaging.

Quantifiable outcome

• 98% accuracy in detecting sleep apnea
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• University of ArizonaflagshipStrategic or Co-development Partner · 12 June 2026Landmark five-year clinical trial comparing three leading treatments for obstructive sleep apnea funded by a nearly $14 million award from PCORI. Daybreak will provide its FDA-cleared oral appliance therapy and patient support services to participants in the OAT (Oral Appliance Therapy) study arm across all trial sites. Study will enroll 2,400 patients across four major academic medical centers comparing CPAP therapy, mandibular advancement device, and pharmacological combination over 12 months of follow-up.
• Veterans Healthcare Supply Solutions (VHSS)coreChannel Partner/ Reseller/ Distributor · 10 June 2026Distribution partnership to make FDA-cleared oral appliance therapy available to veterans through VA Healthcare facilities, Military Treatment Facilities, Department of Defense, and Indian Healthcare Services nationwide. The agreement enables eligible veteran patients to access Daybreak's mandibular advancement device therapy as an alternative to CPAP treatment. Workflow becomes available starting June 22, 2026. Partnership leverages VHSS's federal contracting infrastructure including EDI transaction capabilities and direct-to-patient delivery logistics.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ResMed: Global leader in sleep apnea devices (CPAP/APAP) and connected health platforms. Overlaps with Daybreak in the OSA therapy market, with far deeper payer, sleep-lab, and DME relationships but does not offer an oral appliance line as core focus.
• Philips Respironics: Major OSA device incumbent with broad sleep and respiratory portfolio (CPAP/BiPAP). Comparable as a large-scale OSA therapy provider but does not center its offering on oral appliance therapy or fully at-home virtual care.

Direct peers

• ProSomnus Sleep Technologies: Manufacturer of precision oral appliance therapy devices for OSA, competing directly with the Daybreak Device. Comparable in target patient (CPAP-intolerant adults), device category (custom MAD), and reliance on dentist-prescribed care.
• ApneaMed: Direct-to-patient provider of at-home sleep testing and oral appliance therapy for OSA. Closely mirrors Daybreak's at-home diagnosis plus custom oral device model, including telehealth clinician oversight.
• Lofta: DTC at-home sleep apnea testing and CPAP/alternative therapy provider. Comparable in online funnel, at-home HST, and focus on CPAP-intolerant patients, though Lofta leans more heavily into CPAP dispensing.
• GemStar Manufacturing: Manufacturer of custom oral appliances for OSA and snoring distributed through dental channels. Comparable in MAD product category and dentist-prescribed delivery model.
• BetterNight: Virtual sleep medicine clinic providing at-home sleep testing, diagnosis, and treatment (CPAP and oral appliance alternatives). Overlaps with Daybreak's telehealth-first OSA workflow and target patient population.

Emerging players

• Oventus Medical: Developer of oral appliances for OSA, including proprietary airway technologies. Comparable in targeting mild-to-moderate OSA with custom oral devices, but smaller scale and narrower geographic footprint than Daybreak.
• RemeCare (formerly RePAP): Sleep apnea telehealth and DME provider offering home testing and oral appliance therapy with clinician oversight. Comparable as a digitally led OSA care alternative with a smaller footprint than Daybreak.

Others

• Synchrony Financial: Financing partner that already powers Daybreak's patient installment plans. Relevant as the capital-markets/financing backbone rather than a product competitor — Daybreak's reliance on Synchrony ties patient financing economics to this counterparty.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/thedaybreakco
• Facebookfacebook.com/getdaybreak
• LinkedInlinkedin.com/company/getdaybreak

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Daybreak